Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to ...

Two studies analyzed tau-PET scans from thousands of participants in dozens of cohorts. Tangle prevalence increased with age among cognitively normal people, but decreased among those with dementia.

A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of ...

What if your doctor could, when you turn 65, order a test that predicts whether you are going to develop Alzheimer’s dementia ...

Four years of lecanemab treatment led to less cognitive decline and potentially even improvement in clinical scores over time ...

The first clinical guideline on the use of blood biomarker tests could help clinicians choose the most appropriate test to ...

Know how a groundbreaking brain scan could revolutionise Alzheimer's detection. Understand from an expert how this innovative technology may identify the disease years before symptoms appear.

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai presented the latest findings on lecanemab (Leqembi®) at the Alzheimer's Association International ...

TORONTO -- The antiviral agent valacyclovir demonstrated no benefit in early Alzheimer's disease, the phase II VALAD trial ...